In Depth 29 Oct 2025 Parkinson’s disease: biotech’s pursuit for more therapies Rigorous research aims to boost therapeutic options for people with Parkinson’s disease. What do biotechs have in store? October 29, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 3 Oct 2025Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play This week, we discussed funding with Gerard Caelles, Chief Business Office of Splice Bio, a company that just closed a $135 million series B round. October 3, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 29 Sep 2025 First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? FDA approval for Stealth BioTherapeutics’ elamipretide has been a long time coming. What does this mean for other ultra-rare disease companies? September 29, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2025 Budget blues: where are cell and gene therapies heading? The European Cell & Gene Therapy Summit 2025 was a hotspot for scientists and investors to discuss critical issues faced by the industry. September 17, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Expert Advice 12 Sep 2025 Eight biotech career paths where demand is skyrocketing Check out eight important biotechnology careers that are currently in high demand, and likely still will be in the coming years. September 12, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2025 Kriya Therapeutics has raised over $1.2 billion, but for what? Gene therapies have witnessed a decline in investor interest in recent times. Despite this, Kriya Therapeutics seems to be attracting funds in the space. September 10, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 1 Sep 2025 Blood Cancer Awareness Month: What biotech holds in store As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. September 1, 2025 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Aug 2025 10 biotech companies you should know about in Spain Take a look at some of the top biotech companies you can find in Spain, whose biotech industry has grown dramatically in the last decade. August 19, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 25 Jul 2025Cryoport Systems on the state of the ATMP market and the importance of supply chain resilience In this episode, with Alison Pritchard from Cryoport Systems we look at the ATMP market, the regulatory landscape, and the importance of supply chain resilience. July 25, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 17 Jul 2025 New horizons in sickle cell disease treatment: Promising therapies on the way Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease. July 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 25 Jun 2025 ALS: how close are we to a cure? Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years. June 25, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Jun 2025 Six kidney disease companies you should know about in 2025 Discover six kidney disease companies actively working on innovative treatments that could make a difference to patients’ lives. June 17, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email